IKNA: Nilai perusahaan marang bathi resik ikenaoncology.com

Ikena Oncology - logo grafis emiten IKNA

Ikena Oncology, Inc. (IKNA) is developing innovative therapies for solid tumors, leveraging the secure scientific infrastructure of the US and the humanitarian status of medicine. The price history reflects a current P/E ratio of -2.20. However, the business faces intense pressure from global pharma behemoths that possess massive capital to promote alternative immunotherapeutic methods.

Koefisien rega marang bathi: Ikena (IKNA) kanggo 04.07.2022 - 09.08.2025

Rincian metrik komprehensif lan analitis Ikena Oncology Inc. (IKNA)

- rega saham lan prakiraan rega para ahli:
Ringkesan analisis perusahaan:Ikena Oncology, Inc.
Barang unggulan Ikena Oncology

The P/E ratio reflects the market value of one dollar of net income, allowing for an assessment of the premium paid for an asset. This indicator measures the investment payback period assuming business income remains constant. However, the P/E ratio for Ikena Oncology, Inc. (IKNA) is often distorted due to negative earnings and R&D expenses. The high risk of clinical trial failure and liquidity shortages make the metric volatile. This signals the speculative nature of the capital valuation.

Analisis perusahaan pesaing

ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HALO (Halozyme Inc.)|RVMD (RevMed) - Nilai perusahaan marang bathi resik|Pangali P/E AAPG (ascentage.com)|CGON - Koefisien rega marang bathi|URGN: Koefisien rega marang bathi|BCAX - Pangali P/E|Personalis Corp (PSNL) - Rasio rega marang bathi|Erasca Corp - Nilai perusahaan marang bathi resik|DCTH (Delcath Systems Inc) - Pangali P/E|Kapitalisasi marang bathi Y-mAbs Therapeutics, Inc. YMAB|Pangali P/E AURA|Koefisien rega marang bathi Candel Therapeutics, Inc. CADL|Pangali P/E ARAY (Accuray, Inc.)|SELLAS Life Sciences - Rasio rega marang bathi|ACTU: Koefisien rega marang bathi|Citius Oncology, Inc. - Rasio rega pasar marang bathi resik|HURA (TuHURA Biosciences) - Koefisien rega marang bathi|TARA: Rasio rega pasar marang bathi resik|Koefisien rega marang bathi FATE|WHWK: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi TCRX (TScan Therapeutics Inc)|Periode bali modal bisnis Champions Oncology Inc|Pangali P/E XBIT (XBiotech Inc.)|Nilai perusahaan marang bathi resik CVM|OS Therapies Inc. - Pangali P/E|RADX - Pangali P/E|ARTV: Pangali P/E|ANL: Rasio rega pasar marang bathi resik|Koefisien rega marang bathi VERU|TPST: Nilai perusahaan marang bathi resik|Rasio rega marang bathi xiliotx.com (XLO)|Renovaro - Pangali rega marang bathi|Rasio rega marang bathi Mural Oncology MURA|KAPA - Koefisien rega marang bathi|OKUR - Rasio rega marang bathi|GDTC - Pangali P/E|Curis, Inc. (CRIS) - Rasio rega marang bathi|Koefisien rega marang bathi Apollomics, Inc.|Koefisien rega marang bathi THAR|Pangali rega marang bathi ADVB (Advanced Biomed)|Koefisien rega marang bathi GNPX (Genprex, Inc)|CLDI: Kapitalisasi marang bathi resik|Rasio rega marang bathi sunshinebiopharma.com SBFM|XBIO - Koefisien rega marang bathi|SLRX: Koefisien rega marang bathi|Purple Biotech - Rasio rega pasar marang bathi resik|American Oncology Network (AONC) - Rasio rega marang bathi|Pangali rega marang bathi BGNE|Koefisien rega marang bathi CKPT|Rasio rega marang bathi ELEV|Pangali P/E ICAD|Rasio rega marang bathi NTBL (Notable Labs, Ltd.)|Pangali P/E VIRX (viracta.com)|MOR - Koefisien rega marang bathi|NAYA - Rasio rega marang bathi|Kapitalisasi marang bathi resik AAPGV